Abstract: A phase shifting system, a chip, and a radar sensor are provided. A respective transmission line phase-shifting unit is configured to receive at least one phase shifting control signal and to shift a phase of a RF signal by a first phase or a second phase. Each transmission line phase-shifting unit includes a first group of transmission lines and a second group of transmission lines. At least some transmission lines in the first group of transmission lines of each transmission line phase-shifting unit are physically isolated from at least some transmission lines in the first group of transmission lines of an adjacent transmission line phase-shifting unit and transmission lines of the second group of transmission lines of each transmission line phase-shifting unit are coupled to respective transmission lines of the second group of transmission lines of an adjacent transmission line phase-shifting unit.

Abstract: A transmission line phase shifter, a system, a chip, and a radar sensor are provided. The transmission line phase shifter includes at least one transmission line phase-shifting unit. A respective transmission line phase-shifting unit includes a first pair of differential transmission lines, a second pair of differential transmission lines, and a phase adjusting circuit. The phase adjusting circuit is configured to adjust electrical parameters of a transmission path where at least one pair of transmission lines of the first pair of differential transmission lines and the second pair of differential transmission lines is located according to at least one phase shifting control signal received, so as to enable that a RF signal output from the respective transmission line phase-shifting unit has a phase shift of a first phase or a second phase relative to an input RF signal of the respective transmission line phase-shifting unit.

Abstract: A transmission line phase shifter, a chip, and a radar sensor are provided. The transmission line phase shifter includes at least one transmission line phase-shifting unit. At a calibration stage, a preset number of transmission line phase-shifting units are configured to be in a state of a first phase or in a state of a second phase and configured to output an output RF signal, such that phase calibration information of each transmission line phase-shifting unit is determinable. At an operation stage, the phase adjusting circuit of the respective transmission line phase-shifting unit is configured to receive a corresponding phase shifting control signal and to adjust the respective transmission line phase-shifting unit, to enable the respective transmission line phase-shifting unit to shift a phase of an input RF signal by a calibrated first phase or a calibrated second phase.

Abstract: A radio frequency (RF) inverter, a transmission line phase shifter, a system, a chip, and a radar sensor are provided. The RF inverter includes an inductance circuit and a first phase adjusting circuit that both are arranged symmetrically along a same symmetry axis. The inductance circuit includes a single-ended signal interface and a differential signal interface. The first phase adjusting circuit includes two controlled switches, and each controlled switch is connected between the ground wire and a corresponding ground terminal of a pair of ground terminals in the single-ended signal interface, to enable the inductance circuit to perform in-phase or inverting phase shifting on a received RF signal.

Abstract: This present disclosure relates to the technical field of artificial intelligence, and provides a vessel image classification method and apparatus, a device, and a storage medium. The method includes: inputting a first vessel image sample into a first image processing model, and obtaining a predicted enhanced image and predicted vessel location information; and training the first image processing model based on a second vessel image sample, vessel location labeling information, the predicted enhanced image, and the predicted vessel location information. In the above solution, the impact of image quality on the vessel classification is considered during training of the vessel classification model, so that an end-to-end vessel classification model subsequently generated based on the trained first image processing model can realize a higher classification accuracy for a low quality vessel image, thereby improving the accuracy of classifying vessels in the vessel image by artificial intelligence.

Abstract: A method for storing database security audit records, comprises: S1, when a database server recognizes an auditable event to generate one database security audit record, identifying the database security audit record with a hashed value so that each database security audit record corresponds to a unique hashed value respectively; S2, packaging multiple database security audit records into a database security audit record block; and S3, transmitting the database security audit record block in encrypted way by adopting a peer-to-peer protocol for direct network communication between two nodes, and verifying an ownership of the database security audit record block. The disclosure has the beneficial effects that through an encryption mechanism and a consensus mechanism, storage of database security audit records is achieved in a peer-to-peer network, thereby ensuring that the database security audit records cannot be tampered and forged.

Abstract: A heterocyclic compound as a Syk inhibitor and/or a Syk-HDAC dual inhibitor, or pharmaceutically acceptable salts, prodrugs, deuterated derivatives, hydrates, and solvates thereof are provided. Specifically, a compound of formula (I) is provided, which has dual inhibitory activity for Syk and/or Syk-HDAC.

Abstract: A heterocyclic compound as a Syk inhibitor and/or a Syk-HDAC dual inhibitor, or pharmaceutically acceptable salts, prodrugs, deuterated derivatives, hydrates, and solvates thereof are provided. Specifically, a compound of formula (I) is provided, which has dual inhibitory activity for Syk and/or Syk-HDAC.

Abstract: A method for storing database security audit records, comprises: S1, when a database server recognizes an auditable event to generate one database security audit record, identifying the database security audit record with a hashed value so that each database security audit record corresponds to a unique hashed value respectively; S2, packaging multiple database security audit records into a database security audit record block; and S3, transmitting the database security audit record block in encrypted way by adopting a peer-to-peer protocol for direct network communication between two nodes, and verifying an ownership of the database security audit record block. The disclosure has the beneficial effects that through an encryption mechanism and a consensus mechanism, storage of database security audit records is achieved in a peer-to-peer network, thereby ensuring that the database security audit records cannot be tampered and forged.

Abstract: A heterocyclic compound as a Syk inhibitor and/or a Syk-HDAC dual inhibitor, or pharmaceutically acceptable salts, prodrugs, deuterated derivatives, hydrates, and solvates thereof are provided. Specifically, a compound of formula (I) is provided, which has dual inhibitory activity for Syk and/or Syk-HDAC.

Abstract: A high precision high reliability and quick response thermosensitive chip and manufacturing method thereof is provided, including a thermosensitive ceramic semiconductor substrate; glass protective layers are alternately spray-coated and sintered on the two surfaces of the thermosensitive ceramic semiconductor substrate; and the two surfaces of the thermosensitive ceramic semiconductor substrate having the glass protective layers are printed with metal electrode layers. The thermosensitive chip achieves quick response, accurate control of resistance precision and has high precision; in addition, the glass protective layers thereof enable the thermosensitive chip to have high reliability.

Abstract: The present application relates to the technical field of ultrafast imaging, and provides an ultrafast framing optical imaging device with a real-time high spatial resolution. The optical imaging device includes an ultrashort pulse laser system with a magnitude of femtosecond, a frequency multiplier, a wavelength splitter, a continuous illumination laser, a sampling plate, a calibration camera, a first imaging record module, and a second imaging record module. The present application mainly utilizes continuous light illumination ultrafast events and non-collinear light parameter amplifying technology that uses ultrashort pulse laser to pump/sample events at different moments, and adopts a plurality of CCD cameras to receive corresponding idle light images simultaneously and respectively and thereby realize ultrafast framing optical imaging with a high time resolution.

Abstract: A high precision high reliability and quick response thermosensitive chip and manufacturing method thereof is provided, including a thermosensitive ceramic semiconductor substrate; glass protective layers are alternately spray-coated and sintered on the two surfaces of the thermosensitive ceramic semiconductor substrate; and the two surfaces of the thermosensitive ceramic semiconductor substrate having the glass protective layers are printed with metal electrode layers. The thermosensitive chip achieves quick response, accurate control of resistance precision and has high precision; in addition, the glass protective layers thereof enable the thermosensitive chip to have high reliability.

Abstract: The present application relates to the technical field of ultrafast imaging, and provides an ultrafast framing optical imaging device with a real-time high spatial resolution. The optical imaging device includes an ultrashort pulse laser system with a magnitude of femtosecond, a frequency multiplier, a wavelength splitter, a continuous illumination laser, a sampling plate, a calibration camera, a first imaging record module, and a second imaging record module. The present application mainly utilizes continuous light illumination ultrafast events and non-collinear light parameter amplifying technology that uses ultrashort pulse laser to pump/sample events at different moments, and adopts a plurality of CCD cameras to receive corresponding idle light images simultaneously and respectively and thereby realize ultrafast framing optical imaging with a high time resolution.

Abstract: The present application describes compounds, including all pharmaceutically acceptable salts, prodrugs, solvates and stereoisomers thereof, according to Formula I, pharmaceutical compositions, comprising at least one compound according to Formula I and optionally at least one additional therapeutic agent and methods of treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using compounds according to Formula I

Abstract: The present invention is directed to compounds useful for treating addictive behavior and sleep disorders represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6a, R6b, R7, R8, R9, X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.

Abstract: The present application describes compounds, including all pharmaceutically acceptable salts, prodrugs, solvates and stereoisomers thereof, according to Formula I, pharmaceutical compositions, comprising at least one compound according to Formula I and optionally at least one additional therapeutic agent and methods of treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using compounds according to Formula I

Abstract: The present invention is directed to compounds useful for treating addictive behavior and sleep disorders represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6a, R6b, R7, R8, R9, X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.

Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6a, R6b, R7, R8, R9, X, b, k, m, and n, and the dashed lines are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.

Abstract: The present invention is directed to certain novel compounds represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6a, R6b, R7, R8, R9, X, b, k, m, and n, and the dashed lines are described herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulations in the treatment of certain disorders. The compounds of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraine, conditions associated with cephalic pain, social phobias, and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.